INTERVENE IMMUNE, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2013-01-01
- Employees
- 51
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial
Phase 2
Recruiting
- Conditions
- Epigenetic AgingImmunosenescence
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Intervene Immune, Inc.
- Target Recruit Count
- 85
- Registration Number
- NCT04375657
- Locations
- 🇺🇸
Intervene Immune, Torrance, California, United States
News
No news found